AI tool may support dermatologists in assessing skin lesions for cancer risk

AI Summary

Mayo Clinic researchers report that an AI tool may help dermatologists evaluate whether skin lesions are cancerous. The tool is intended to support decisions about biopsy or monitoring, rather than replace clinicians.

Mayo Clinic researchers have found that an artificial intelligence (AI) tool may provide dermatologists with additional information to help assess whether skin lesions are cancerous and inform their clinical decisions about whether to biopsy or monitor them, according to a study published in Mayo Clinic Proceedings.